Alexandra Balcom
Vermögen: - $ am 31.07.2026
Vermögen: - $ am 31.07.2026
Alexandra Balcom is currently an Independent Director at Crescent Biopharma, Inc. since 2024.
Former roles include Director at Crescent Biopharma, Inc. (Old), Controller at Agios Pharmaceuticals, Inc., Vice President-Finance at SQZ Biotechnologies Co. from 2017 to 2021, and Chief Financial Officer & Treasurer at Nuvalent, Inc. from 2021 to 2026.
Education includes an MBA from Boston College and an undergraduate degree from the University of Massachusetts.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 02.06.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|
| Unternehmen | Position | Ende |
|---|---|---|
| NUVALENT, INC. | Finanzdirektor/CFO | 15.07.2026 |
| SQZ BIOTECHNOLOGIES COMPANY | Corporate Officer/Principal | 01.03.2021 |
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
SQZ Biotechnologies Co.
SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen